Avio S.p.A. Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw 20% revenue growth, robust backlog, and progress in launch and defense segments. Guidance is confirmed, with strong demand and new U.S. contracts, but energy costs and defense order timing remain risks.
Fiscal Year 2025
-
Record 2025 results with backlog at EUR 2.2 billion and revenues up 23% year-over-year. Defense backlog surged to EUR 600 million, and strong cash position enables U.S. expansion. 2026 guidance is cautious due to geopolitical uncertainty but anticipates continued growth.
-
Record backlog and 26% revenue growth driven by strong order intake in space and defense, with EBITDA up despite energy costs. Capital increase supports U.S. expansion, and guidance for year-end is confirmed, with long-term targets showing significant growth in defense and U.S. markets.
-
H1 2025 saw 30% revenue and 24% EBITDA growth, with a €1.7B backlog and strong order momentum in both space and defense. A €400M capital increase will fund a major U.S. plant and European expansion, supporting a 10% annual revenue growth target and a shift toward defense.
-
Q1 2025 saw a 35% revenue increase, strong backlog, and successful launches, with guidance reaffirmed for 2025. Production ramp-up and defense order growth are on track, while new U.S. and European contracts and a U.S. plant support long-term expansion.
Fiscal Year 2024
-
Record revenues and backlog were achieved, driven by strong defense propulsion growth and successful Vega C and Ariane 6 launches. 2025 is expected to bring further revenue and EBITDA growth, with a focus on margin improvement and capacity expansion to meet rising defense and space demand.
-
Revenues grew 25% year-over-year, driven by defense propulsion and technology projects, with a record EUR 1.3 billion order backlog. 2024 guidance is confirmed, anticipating further growth from defense contracts and a busy 2025 launch schedule.
-
H1 2024 saw record backlog, 15% revenue growth, and strong defense propulsion gains. U.S. contracts and Ariane 6 success support a positive outlook, with guidance confirmed for 2024 and non-recurring costs set to decline.